These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 9660430

  • 1. Postmenopausal dehydroepiandrosterone administration increases free insulin-like growth factor-I and decreases high-density lipoprotein: a six-month trial.
    Casson PR, Santoro N, Elkind-Hirsch K, Carson SA, Hornsby PJ, Abraham G, Buster JE.
    Fertil Steril; 1998 Jul; 70(1):107-10. PubMed ID: 9660430
    [Abstract] [Full Text] [Related]

  • 2. The effect of six months treatment with a 100 mg daily dose of dehydroepiandrosterone (DHEA) on circulating sex steroids, body composition and muscle strength in age-advanced men and women.
    Morales AJ, Haubrich RH, Hwang JY, Asakura H, Yen SS.
    Clin Endocrinol (Oxf); 1998 Oct; 49(4):421-32. PubMed ID: 9876338
    [Abstract] [Full Text] [Related]

  • 3. Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age.
    Morales AJ, Nolan JJ, Nelson JC, Yen SS.
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1360-7. PubMed ID: 7515387
    [Abstract] [Full Text] [Related]

  • 4. Oral dehydroepiandrosterone supplementation modulates spontaneous and growth hormone-releasing hormone-induced growth hormone and insulin-like growth factor-1 secretion in early and late postmenopausal women.
    Genazzani AD, Stomati M, Strucchi C, Puccetti S, Luisi S, Genazzani AR.
    Fertil Steril; 2001 Aug; 76(2):241-8. PubMed ID: 11476767
    [Abstract] [Full Text] [Related]

  • 5. Lack of dehydroepiandrosterone effect on a combined endurance and resistance exercise program in postmenopausal women.
    Igwebuike A, Irving BA, Bigelow ML, Short KR, McConnell JP, Nair KS.
    J Clin Endocrinol Metab; 2008 Feb; 93(2):534-8. PubMed ID: 18029465
    [Abstract] [Full Text] [Related]

  • 6. Low dose dehydroepiandrosterone affects behavior in hypopituitary androgen-deficient women: a placebo-controlled trial.
    Johannsson G, Burman P, Wirén L, Engström BE, Nilsson AG, Ottosson M, Jonsson B, Bengtsson BA, Karlsson FA.
    J Clin Endocrinol Metab; 2002 May; 87(5):2046-52. PubMed ID: 11994339
    [Abstract] [Full Text] [Related]

  • 7. Dehydroepiandrosterone reduces serum low density lipoprotein levels and body fat but does not alter insulin sensitivity in normal men.
    Nestler JE, Barlascini CO, Clore JN, Blackard WG.
    J Clin Endocrinol Metab; 1988 Jan; 66(1):57-61. PubMed ID: 2961787
    [Abstract] [Full Text] [Related]

  • 8. Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause.
    Stomati M, Monteleone P, Casarosa E, Quirici B, Puccetti S, Bernardi F, Genazzani AD, Rovati L, Luisi M, Genazzani AR.
    Gynecol Endocrinol; 2000 Oct; 14(5):342-63. PubMed ID: 11109974
    [Abstract] [Full Text] [Related]

  • 9. Androgens, insulin-like growth factor-I (IGF-I), and carrier proteins (SHBG, IGFBP-3) in postmenopause.
    Gambera A, Scagliola P, Falsetti L, Sartori E, Bianchi U.
    Menopause; 2004 Oct; 11(2):159-66. PubMed ID: 15021445
    [Abstract] [Full Text] [Related]

  • 10. Metabolic effects of 12-month percutaneous dehydroepiandrosterone replacement therapy in postmenopausal women.
    Diamond P, Cusan L, Gomez JL, Bélanger A, Labrie F.
    J Endocrinol; 1996 Sep; 150 Suppl():S43-50. PubMed ID: 8943786
    [Abstract] [Full Text] [Related]

  • 11. Dehydroepiandrosterone (DHEA) replacement reduces growth hormone (GH) dose requirement in female hypopituitary patients on GH replacement.
    Brooke AM, Kalingag LA, Miraki-Moud F, Camacho-Hübner C, Maher KT, Walker DM, Hinson JP, Monson JP.
    Clin Endocrinol (Oxf); 2006 Nov; 65(5):673-80. PubMed ID: 17054472
    [Abstract] [Full Text] [Related]

  • 12. Replacement of dehydroepiandrosterone enhances T-lymphocyte insulin binding in postmenopausal women.
    Casson PR, Faquin LC, Stentz FB, Straughn AB, Andersen RN, Abraham GE, Buster JE.
    Fertil Steril; 1995 May; 63(5):1027-31. PubMed ID: 7720912
    [Abstract] [Full Text] [Related]

  • 13. Long-term low-dose dehydroepiandrosterone oral supplementation in early and late postmenopausal women modulates endocrine parameters and synthesis of neuroactive steroids.
    Genazzani AD, Stomati M, Bernardi F, Pieri M, Rovati L, Genazzani AR.
    Fertil Steril; 2003 Dec; 80(6):1495-501. PubMed ID: 14667889
    [Abstract] [Full Text] [Related]

  • 14. Effects of conjugated equine estrogen vs. raloxifene on serum insulin-like growth factor-i and insulin-like growth factor binding protein-3: a 2-year, double-blind, placebo-controlled study.
    Duschek EJ, de Valk-de Roo GW, Gooren LJ, Netelenbos C.
    Fertil Steril; 2004 Aug; 82(2):384-90. PubMed ID: 15302288
    [Abstract] [Full Text] [Related]

  • 15. Increases in bone mineral density in response to oral dehydroepiandrosterone replacement in older adults appear to be mediated by serum estrogens.
    Jankowski CM, Gozansky WS, Kittelson JM, Van Pelt RE, Schwartz RS, Kohrt WM.
    J Clin Endocrinol Metab; 2008 Dec; 93(12):4767-73. PubMed ID: 18812486
    [Abstract] [Full Text] [Related]

  • 16. Influence of some biological indexes on sex hormone-binding globulin and androgen levels in aging or obese males.
    Vermeulen A, Kaufman JM, Giagulli VA.
    J Clin Endocrinol Metab; 1996 May; 81(5):1821-6. PubMed ID: 8626841
    [Abstract] [Full Text] [Related]

  • 17. Age-dependent changes in body composition in postmenopausal Japanese women: relationship to growth hormone secretion as well as serum levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3.
    Sugimoto T, Nakaoka D, Nasu M, Kanzawa M, Sugishita T, Chihara K.
    Eur J Endocrinol; 1998 Jun; 138(6):633-9. PubMed ID: 9678529
    [Abstract] [Full Text] [Related]

  • 18. Activation of immune function by dehydroepiandrosterone (DHEA) in age-advanced men.
    Khorram O, Vu L, Yen SS.
    J Gerontol A Biol Sci Med Sci; 1997 Jan; 52(1):M1-7. PubMed ID: 9008662
    [Abstract] [Full Text] [Related]

  • 19. Sex-specific effects of dehydroepiandrosterone (DHEA) on bone mineral density and body composition: A pooled analysis of four clinical trials.
    Jankowski CM, Wolfe P, Schmiege SJ, Nair KS, Khosla S, Jensen M, von Muhlen D, Laughlin GA, Kritz-Silverstein D, Bergstrom J, Bettencourt R, Weiss EP, Villareal DT, Kohrt WM.
    Clin Endocrinol (Oxf); 2019 Feb; 90(2):293-300. PubMed ID: 30421439
    [Abstract] [Full Text] [Related]

  • 20. Effects of intranasal 17beta-estradiol on bone turnover and serum insulin-like growth factor I in postmenopausal women.
    Garnero P, Tsouderos Y, Marton I, Pelissier C, Varin C, Delmas PD.
    J Clin Endocrinol Metab; 1999 Jul; 84(7):2390-7. PubMed ID: 10404809
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.